Reality stars hawk allergy drugs

Share this article:
Reality stars hawk allergy drugs
Reality stars hawk allergy drugs
Spring is in the air, and that means, well, sure, robins, daffodils, love and all that, but more importantly, campaigns for allergy drugs featuring endorsements by B-list celebrity sufferers.

This season's famous sneezers include soap star-turned-reality show host Alison Sweeney for McNeil Consumer's Zyrtec Liquid Gels and American Idol judge Kara DioGuardi for Merck's Claritin.

Sweeney, a longtime Days of Our Lives star and host of The Biggest Loser, took part in a Zyrtec event in which she raced six people in nose costumes. Dubbed “Race Against Your Allergies,” the stunt took place in New York City's Madison Square Park and delighted onlookers, including a few MM&M staffers.  

“With new Zyrtec Liquid Gels, people can get relief at liquid speed,” quipped McNeil VP marketing, upper respiratory Rohinish Hooda.

Meanwhile, DioGuardi is serving as the face of Claritin's Living Clear campaign, a user-generated content effort that invites users to submit a video to LivingClear.com showing what Claritin's non-drowsy formula has enabled them to do. Finalists will be announced May 6, and votes from visitors will decide the ultimate winner, who will pocket a $10,000 prize and win a chance to star in a Claritin online ad, while five finalists take home $1,000 and a one-year supply of Claritin products.
Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZeneca beefs up respiratory portfolio

AstraZeneca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.